Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. Guidelines, Ann Dermatol V en er eol, vol.136, pp.177-86, 2009. ,
Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study, J Cutan Pathol, vol.37, pp.20-27, 2010. ,
Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases, Br J Dermatol, vol.175, pp.1382-1388, 2016. ,
Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases, Eur J Dermatol EJD, vol.28, pp.78-81, 2018. ,
Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma, J Eur Acad Dermatol Venereol, vol.32, pp.257-265, 2018. ,
Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab, J Clin Med, vol.7, p.10, 2018. ,
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma, N Engl J Med, vol.379, pp.341-51, 2018. ,
PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma, N Engl J Med, vol.374, pp.2542-52, 2016. ,
Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC), Cancer Res, vol.77, pp.74-074, 2017. ,
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ?1 year of follow-up: JAVELIN Merkel ,